Literature DB >> 22005141

The beers criteria as an outpatient screening tool for potentially inappropriate medications.

Rebecca L Dunn1, Donald Harrison, Toni L Ripley.   

Abstract

OBJECTIVE: To determine the impact of using the Beers criteria (sometimes known as the Beers list) as an outpatient screening tool on the number or dosage of Beers criteria medications identified in patients' medication profiles immediately before an outpatient appointment.
DESIGN: Nonrandomized, prospective pre-/post pilot study.
SETTING: Six individual medicine and medicine-specialty clinics at a major academic medical center. PARTICIPANTS: All subjects were 65 years of age or older.
INTERVENTIONS: Subjects 65 years of age or older had their medication profiles screened using the Beers criteria- medications potentially inappropriate for use in the elderly- prior to and directly after a scheduled appointment with their physician. Respective physicians were notified of any Beers criteria medications before the appointments. Physician options were to discontinue, continue, or change the dose of the medications identified with the option for justification of their decision. MAIN OUTCOME MEASURE: The difference from baseline (preappointment) to follow-up (postappointment) in the number or dosage of Beers criteria medications identified in patients' profiles.
RESULTS: 120 eligible charts were reviewed. The average age of subjects was 74 years. Overall, 37.5% of subjects were on potentially inappropriate medications (PIMs) as defined by the Beers criteria. Sixty-three PIMs were flagged out of 120 profiles. For the primary outcome, 8/63 and 0/63 PIMs were discontinued or had a dosage change, respectively. This intervention resulted in a statistically significant reduction in the mean number of Beers criteria medications (P = 0.032).
CONCLUSION: Use of the Beers criteria as a clinical intervention tool in an outpatient setting may be an effective method to reduce the number of PIMs prescribed in an elderly population.

Entities:  

Mesh:

Year:  2011        PMID: 22005141     DOI: 10.4140/TCP.n.2011.754

Source DB:  PubMed          Journal:  Consult Pharm        ISSN: 0888-5109


  7 in total

Review 1.  Interventions to deprescribe potentially inappropriate medications in the elderly: Lost in translation?

Authors:  Andrew D Baumgartner; Collin M Clark; Susan A LaValley; Scott V Monte; Robert G Wahler; Ranjit Singh
Journal:  J Clin Pharm Ther       Date:  2019-12-24       Impact factor: 2.512

2.  Effect of a Pharmacist-Driven Medication Management Intervention Among Older Adults in an Inpatient Setting.

Authors:  Sara Alosaimy; Alka Vaidya; Kevin Day; Gretchen Stern
Journal:  Drugs Aging       Date:  2019-04       Impact factor: 3.923

3.  Doctors' perspectives on the barriers to appropriate prescribing in older hospitalized patients: a qualitative study.

Authors:  Shane Cullinan; Aoife Fleming; Denis O'Mahony; Cristin Ryan; David O'Sullivan; Paul Gallagher; Stephen Byrne
Journal:  Br J Clin Pharmacol       Date:  2015-05       Impact factor: 4.335

Review 4.  A meta-synthesis of potentially inappropriate prescribing in older patients.

Authors:  Shane Cullinan; Denis O'Mahony; Aoife Fleming; Stephen Byrne
Journal:  Drugs Aging       Date:  2014-08       Impact factor: 3.923

5.  The impact of a structured pharmacist intervention on the appropriateness of prescribing in older hospitalized patients.

Authors:  David O'Sullivan; Denis O'Mahony; Marie N O'Connor; Paul Gallagher; Shane Cullinan; Richard O'Sullivan; James Gallagher; Joseph Eustace; Stephen Byrne
Journal:  Drugs Aging       Date:  2014-06       Impact factor: 3.923

Review 6.  STOPP/START criteria for potentially inappropriate prescribing in older people: version 2.

Authors:  Denis O'Mahony; David O'Sullivan; Stephen Byrne; Marie Noelle O'Connor; Cristin Ryan; Paul Gallagher
Journal:  Age Ageing       Date:  2014-10-16       Impact factor: 10.668

7.  Geriatric Depression and Inappropriate Medication: Benefits of Interprofessional Team Cooperation in Nursing Homes.

Authors:  Hana Vankova; Iva Holmerova; Ladislav Volicer
Journal:  Int J Environ Res Public Health       Date:  2021-11-26       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.